These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54. Optimized human factor IX expression cassettes for hepatic-directed gene therapy of hemophilia B. Zhang R; Wang Q; Zhang L; Chen S Front Med; 2015 Mar; 9(1):90-9. PubMed ID: 25663062 [TBL] [Abstract][Full Text] [Related]
55. Gene therapy ethics and haemophilia: an inevitable therapeutic future? Dimichele D; Miller FG; Fins JJ Haemophilia; 2003 Mar; 9(2):145-52. PubMed ID: 12614364 [TBL] [Abstract][Full Text] [Related]
56. Genetic engineering for haemophilia A. Gan SU; Kon OL; Calne RY Expert Opin Biol Ther; 2006 Oct; 6(10):1023-30. PubMed ID: 16989584 [TBL] [Abstract][Full Text] [Related]
57. Adeno-associated virus (AAV) vectors in cancer gene therapy. Santiago-Ortiz JL; Schaffer DV J Control Release; 2016 Oct; 240():287-301. PubMed ID: 26796040 [TBL] [Abstract][Full Text] [Related]
58. Haemophilia, state of the art and new therapeutic opportunities, a regulatory perspective. Tomeo F; Mariz S; Brunetta AL; Stoyanova-Beninska V; Penttila K; Magrelli A Br J Clin Pharmacol; 2021 Nov; 87(11):4183-4196. PubMed ID: 33772837 [TBL] [Abstract][Full Text] [Related]
59. Gene therapy for haemophilia: a long and winding road. High KA J Thromb Haemost; 2011 Jul; 9 Suppl 1():2-11. PubMed ID: 21781236 [TBL] [Abstract][Full Text] [Related]